Century Therapeutics, Inc. (IPSC): Total Assets
$223.70M
As of 2025-12-31
$287.01M
As of 2026-06-30
-22.8%
3-year compound annual growth
+15.9%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $223.70M | -36.7% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $353.22M | -2.1% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $360.69M | -25.9% | 2025-03-19, Balance as of period end |
| 2022-12-31 | $486.54M | +11.2% | 2024-03-14, Balance as of period end |
| 2021-12-31 | $437.38M | +309.6% | 2023-03-16, Balance as of period end |
| 2020-12-31 | $106.78M | n/a | 2022-03-17, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | 2025-12-31 | $223.70M | -36.7% |
| ImmunityBio, Inc. (IBRX) | 2025-12-31 | $501.90M | +31.1% |
| Agenus Inc (AGEN) | 2025-12-31 | $226.80M | +0.2% |
| Sutro Biopharma, Inc. (STRO) | 2025-12-31 | $173.83M | -55.1% |
| Atara Biotherapeutics, Inc. (ATRA) | 2025-12-31 | $20.23M | -81.5% |
| Monte Rosa Therapeutics, Inc. (GLUE) | 2025-12-31 | $448.66M | +2.3% |
| Beam Therapeutics Inc. (BEAM) | 2025-12-31 | $1.48B | +34.2% |
| 4D Molecular Therapeutics, Inc. (FDMT) | 2025-12-31 | $566.71M | +1.1% |
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | $244.43M | -9.4% |
Compare IPSC, IBRX, AGEN, STRO side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗